title: Reply to UN Das.
authors.forename: Ahmed A
authors.initials: AA
authors.lastname: Daak
authors.forename: Kebreab
authors.initials: K
authors.lastname: Ghebremeskel
authors.forename: Zahir
authors.initials: Z
authors.lastname: Hassan
authors.forename: Bakhita
authors.initials: B
authors.lastname: Attallah
authors.forename: Haj H
authors.initials: HH
authors.lastname: Azan
authors.forename: Mustafa I
authors.initials: MI
authors.lastname: Elbashir
authors.forename: Michael
authors.initials: M
authors.lastname: Crawford
mesh_terms: D000755:Anemia, Sickle Cell / Q000188:drug therapy*; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D019587:Dietary Supplements; D015525:Fatty Acids, Omega-3 / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D014665:Vasodilator Agents / Q000627:therapeutic use*
chemical_list: D000893:Anti-Inflammatory Agents; D015525:Fatty Acids, Omega-3; D014665:Vasodilator Agents